ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Nutex Health's annualized net income for the quarter that ended in Dec. 2023 was $-126.5 Mil. Nutex Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $75.7 Mil. Therefore, Nutex Health's annualized ROE % for the quarter that ended in Dec. 2023 was -167.09%.
The historical rank and industry rank for Nutex Health's ROE % or its related term are showing as below:
NUTX'
s ROE % Range Over the Past 10 Years
Min: -403.56 Med: 73.91 Max: 185.72
Current: -52.93
During the past 5 years, Nutex Health's highest ROE % was 185.72%. The lowest was -403.56%. And the median was 73.91%.
NUTX's ROE % is ranked worse than 86.44% of 612
companies
in the Healthcare Providers & Services industry
Industry Median: 4.035
vs NUTX: -52.93
Nutex Health ROE % Historical Data
The historical data trend for Nutex Health's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Nutex Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health's ROE % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's ROE % distribution charts can be found below:
* The bar in red indicates where Nutex Health's ROE % falls into.
Nutex Health ROE % Calculation
Nutex Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2023) net income data.
ROE % is displayed in the 30-year financial page.
Nutex Health (NAS:NUTX) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Nutex Health ROE % Related Terms
Thank you for viewing the detailed overview of Nutex Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nutex Health Inc is healthcare services and operations company with 19 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NUTX has been successfully added to your 